RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY January 2024 slide deck - over 120 panc pts studiedwhat a pity that Pela doesn't cure delusions...
You are so wrong Noteable its almost beyond ridiculous... but the shameful thing is you keep stating that the ones challenging the pumpers on this bb are part of some scheme to aquire ONCY on the cheap... well, If ONCY were to release data that unassailably demonstrates with statisitical significance that Pela in combo is effective in treating Panc and mBC patients then the price wouldn't be so cheap... year after year we wait on Phase II trials for which no prove can be taken because they are underpowered.
IND-213 was a randomised Phase II trial, FDA awarded ONCY with a SPA at the end of Phase II meeting, and all ONCY had to do was then re-run IND-213 with 450 or so patients in a Phase III... that was 2018... so it is ONCY mismanagement and their inablility to generate BD interest that has left this company's stock price floundering... NOT the few of us here who have been pointing this out.
Either prove your accusations, or desist.